Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays

Cell Biology International

Volumn 36, Issue 12, 2012, Pages 1137-1143

  Warrier, Sudha ^a   Pavanram, Prathyusha ^a   Raina, Dhruv ^a   Arvind, Milan ^a  

^a Manipal Academy of Higher Education   (India)

Author keywords

Cancer stem cells; CD133; Doxorubicin; Drug resistance; Glioblastoma; Neurospheres

Indexed keywords

ABC TRANSPORTER; ATP BINDING CASSETTE TRANSPORTER C2; ATP BINDING CASSETTE TRANSPORTER C4; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CELL ASSAY; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL SUSPENSION; CELL VIABILITY; CELLULAR DISTRIBUTION; COLONY FORMING UNIT; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE CELL ANALYSIS;

EID: 84871999193     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110539     Document Type: Article

References (28)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-8.
2. Balzarotti M, Ciusani E, Calatozzolo C, Croci D, Boiardi A, Salmaggi A. Effect of association of temozolomide with other chemotherapic agents on cell growth inhibition in glioma cell lines. Oncol Res 2004;14:325-30.
3. Bernardi A, Jacques-Silva MC, Delgado-Cañedo A, Lenz G, Battastini AM. Nonsteroidal anti-inflammatory drugs inhibit the growth of C6 and U138-MG glioma cell lines. Eur J Pharmacol 2006;532:214-22.
4. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-7.
5. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946-51.
6. Collins AT, Maitland NJ. Prostate cancer stem cells. Eur J Cancer 2006;42:1213-8.
7. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005;5:275-84.
8. Dick JE. Breast cancer stem cells revealed. Proc Natl Acad Sci USA 2003;100:3547-9.
9. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011-21.
10. Gopinath S, Vanamala SK, Gujrati M, Klopfenstein JD, Dinh DH, Rao JS. Doxorubicin-mediated apoptosis in glioma cells requires NFAT3. Cell Mol Life Sci 2009;66:3967-78.
11. Hjelmeland AB, Wu Q, Wickman S, Eyler C, Heddleston J, Shi Q et al. Targeting A20 decreases glioma stem cell survival and tumor growth. PLoS Biol 2010;23:8.
12. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994;367:645-8.
13. Lathia JD, Hitomi M, Gallagher J, Gadani SP, Adkins J, Vasanji A et al. Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis 2011;2:e200.
14. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006;9:391-403.
15. Li HZ, Yi T B, Wu ZY. Suspension culture combined with anticancer regimens for screening breast cancer stem cells. Med Hypotheses 2007;68:988-90.
16. Lin X, Li Q, Wang YJ, Ju YW, Chi ZQ, Wang MW et al. Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells. Biochem J 2007;406:215-21.
17. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006;5:67.
18. Liu Q, Nguyen DH, Dong Q, Shitaku P, Chung K, Liu OY et al. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. J Neurooncol 2009;94:1-19.
19. Passegue E, Jamieson CH, Ailles LE, Weissman IL. Normal and leukemic hematopoiesis are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 2003;100:11842-9.
20. Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, Liu W et al. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett 2009;279:13-21.
21. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11.
22. Sharom FJ. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 2008;9:105-27.
23. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-8.
24. Singh SK, Hawkins C, Clarke ID, Squire J A, Bayani J, Hide T et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401.
25. Wang F, Bhat K, Doucette M, Zhou S, Gu Y, Law B et al. Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis. Curr Mol Med 2011;11:503-11.
26. Wolff JE, Trilling T, Mö lenkamp G, Egeler RM, Jü rgens H. Chemosensitivity of glioma cells in vitro: a meta analysis. J Cancer Res Clin Oncol 1999;125:481-6.
27. Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH, Yao XH et al. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett 2008;265:124-34.
28. Zhou BB, Zhang H, Samelin M, Geles KG, Grindley JC et al. Tumour initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 2009;8:806-23.